Wen‐Fang Cheng
- Molecular Biology top 2%
- Immunology top 1%
- Oncology top 1%
- Cancer Research top 1%
- Epidemiology top 2%
- Co-authors
- Chi‐An ChenT.‐C. WuChien‐Fu HungYu‐Li ChenMorris LingChang‐Yao HsiehChee‐Yin ChaiYing‐Cheng Chiang
- Topics
- Ovarian cancer diagnosis and treatment (62 papers)Endometrial and Cervical Cancer Treatments (60 papers)Immunotherapy and Immune Responses (45 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Wen‐Fang Cheng
278 papers receiving 7.8k citations
Peers
Comparison fields: 5 of 153
- Molecular Biology 3.2k
- Immunology 2.2k
- Oncology 1.7k
- Cancer Research 1.6k
- Epidemiology 1.4k
Countries citing papers authored by Wen‐Fang Cheng
This map shows the geographic impact of Wen‐Fang Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen‐Fang Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen‐Fang Cheng more than expected).
Fields of papers citing papers by Wen‐Fang Cheng
This network shows the impact of papers produced by Wen‐Fang Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen‐Fang Cheng. The network helps show where Wen‐Fang Cheng may publish in the future.
Co-authorship network of co-authors of Wen‐Fang Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Wen‐Fang Cheng. A scholar is included among the top collaborators of Wen‐Fang Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen‐Fang Cheng. Wen‐Fang Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 2 | |
| 10 | 114 | |
| 11 | 50 | |
| 12 | 39 | |
| 13 | 16 | |
| 14 | Abstract 17934: Bevacizumab for Plaque Stabilization: Evaluation of its Effect on Vasa Vasorum, Lipid Pool, and Atheroma Volume by Multimodality Imaging Techniques in an Atherosclerotic Rabbit Model | 3 |
| 15 | 19 | |
| 16 | 3 | |
| 17 | 72 | |
| 18 | 215 | |
| 19 | 53 | |
| 20 | 118 |
About Wen‐Fang Cheng
Wen‐Fang Cheng is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Immunology, having authored 291 papers that have together received 8.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (62 papers), Endometrial and Cervical Cancer Treatments (60 papers) and Immunotherapy and Immune Responses (45 papers). The work is most often cited by research in Reproductive Medicine (1.2k citations), Obstetrics and Gynecology (1.1k citations) and Cancer Research (1.6k citations). Wen‐Fang Cheng has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Chi‐An Chen, T.‐C. Wu, Chien‐Fu Hung, Yu‐Li Chen, Morris Ling, Chang‐Yao Hsieh, Chee‐Yin Chai, Ying‐Cheng Chiang, Keng‐Fu Hsu and Chien‐Nan Lee. Their work appears in journals such as Circulation, Journal of Clinical Investigation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.